784
Participants
Start Date
November 30, 2025
Primary Completion Date
November 30, 2028
Study Completion Date
April 30, 2029
Isoniazid (H)
H, weight based, 150-375mg
Rifampicin (R)
R, weight based, 300-750mg
Pyrazinamide (Z)
Z, weight based, 800-2000mg
Ethambutol (E)
E weight based, 550-1375mg
National University of Medical Sciences, Islamabad
Clinical HIV Research Unit, Wits Health Consortium, Johannesburg
The Aurum Institute, Johannesburg
Bulawayo City Health, Bulawayo
Collaborators (1)
National University of Medical Sciences, Pakistan
OTHER
Aurum Institute
OTHER
Biomedical Research and Training Institute, Zimbabwe
OTHER
Foundation for Innovative New Diagnostics, Switzerland
OTHER
KTH Royal Institute of Technology
OTHER
London School of Hygiene and Tropical Medicine
OTHER
Wits Health Consortium (Pty) Ltd
OTHER
University College, London
OTHER